M. Kathryn Fink - Sep 13, 2024 Form 4 Insider Report for STRYKER CORP (SYK)

Signature
/s/ Austin Y. Ke, attorney-in-fact for M Kathryn Fink
Stock symbol
SYK
Transactions as of
Sep 13, 2024
Transactions value $
-$2,580,875
Form type
4
Date filed
9/17/2024, 06:01 PM
Previous filing
May 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYK Common Stock Sale -$785K -2.12K -17.44% $370.00 10K Sep 13, 2024 Direct F1
transaction SYK Common Stock Options Exercise $900K +7.35K +73.16% $122.51 17.4K Sep 16, 2024 Direct
transaction SYK Common Stock Sale -$93.2K -258 -1.48% $361.21 17.1K Sep 17, 2024 Direct F1, F2
transaction SYK Common Stock Sale -$484K -1.34K -7.8% $362.23 15.8K Sep 17, 2024 Direct F1, F3
transaction SYK Common Stock Sale -$172K -474 -3% $363.28 15.3K Sep 17, 2024 Direct F1, F4
transaction SYK Common Stock Sale -$232K -635 -4.14% $364.57 14.7K Sep 17, 2024 Direct F1, F5
transaction SYK Common Stock Sale -$178K -487 -3.32% $365.31 14.2K Sep 17, 2024 Direct F1, F6
transaction SYK Common Stock Sale -$342K -931 -6.56% $367.16 13.3K Sep 17, 2024 Direct F1, F7
transaction SYK Common Stock Sale -$169K -460 -3.47% $367.98 12.8K Sep 17, 2024 Direct F1, F8
transaction SYK Common Stock Sale -$251K -680 -5.31% $369.05 12.1K Sep 17, 2024 Direct F1, F9
transaction SYK Common Stock Sale -$49.7K -134 -1.1% $370.64 12K Sep 17, 2024 Direct F1, F10
transaction SYK Common Stock Sale -$569K -1.53K -12.76% $371.58 10.5K Sep 17, 2024 Direct F1, F11
transaction SYK Common Stock Sale -$157K -422 -4.03% $372.56 10K Sep 17, 2024 Direct F1, F12
holding SYK Common Stock 398 Sep 13, 2024 By 401K

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYK Employee Stock Option granted 02/08/2017 (right to buy) Options Exercise $0 -7.35K -100% $0.00 0 Sep 16, 2024 Common Stock 7.35K $122.51 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024.
F2 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $360.785 to $361.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $361.865 to $362.72, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $362.84 to $363.835, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F5 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.215 to $364.92, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F6 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.935 to $365.925, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F7 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $366.56 to $367.56, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F8 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $367.625 to $368.585, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F9 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $368.735 to $369.645, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F10 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $369.855 to $370.79, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F11 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $370.87 to $371.87, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F12 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $372.205 to $373.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F13 Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.